Movatterモバイル変換

Abstract

Pregnancy in a diabetic woman brings about many changes that can lead to the development of diabetic retinopathy (DR) or worsening of pre-existing disease. In some patients this may develop into sight threatening disease which, if not treated adequately, can cause devastating visual impairment. There is a lack of established guidelines for screening these patients during pregnancy. In this article we discuss the physiological changes during pregnancy that contribute to worsening of diabetic retinopathy and review the relative contribution of risk factors to the underlying pathological processes. It is important to identify and treat any pre-existing retinopathy in diabetic women considering pregnancy and optimise glycaemic control prior to conception. Rapid tightening of glycaemic control after conception is associated with a less favourable outcome. Based on the existing literature we suggest guidelines for diabetic retinopathy screening for women during pregnancy. Established sight-threatening retinopathy should be treated at an earlier stage in pregnant women compared to non-pregnant diabetics with a similar disease.

Keywords:Diabetic retinopathy,Diabetes mellitus,Pregnancy,Laser photocoagulation,Screening

Rights & Permissions Print Cite

Call for Papers in Thematic Issues

Submission closes on : 31 December, 2025

Advancing Diabetic Wound Healing: Mechanisms and Interventions

In recent years, diabetic wounds have become a global health concern with an increase in the incidence of diabetes. Diabetic wounds are a kind of chronic and refractory ulcer. It is generally due to microcirculatory disturbances and reduced levels of endogenous growth factors. Delayed cutaneous wound healing is a chronic ...read more

Guest Editor(s): Dr. Manish Gautam

Submission closes on : 05 January, 2026

Advancing Insights into Type 1 Diabetes: From Mechanisms to Management

Type 1 diabetes (T1D) represents a significant global health challenge, requiring a deep understanding of its complex pathophysiology and the development of innovative strategies for prevention, treatment, and management. This thematic issue highlights the latest progress in understanding the autoimmune processes underlying T1D, advances in beta-cell biology, and novel therapeutic ...read more

Guest Editor(s):Dr. Jun Tang

Submission closes on : 06 April, 2026

Exerscience: management of diabetes by physical activity/exercise

Physical activity/exercise is key to the management of diabetes and its complications. Studies have suggested that increased physical activity or regular exercise is associated with reduced risks of diabetes and its complications. However, challenges remained on how to promote physical activity or exercise efficiently, e.g., increase the adherence to physical ...read more

Guest Editor(s): Shanhu Qiu

Submission closes on : 01 June, 2026

Next-Generation Drug Delivery Systems for Diabetes: Nanoparticles, Hydrogels, and Phytosome Technologies

This thematic issue, titled "Next-Generation Drug Delivery Systems for Diabetes: Nanoparticles, Hydrogels, and Phytosome Technologies," will focus on advanced formulation science to enhance diabetes treatment. It covers innovative platforms such as nanoparticles, responsive hydrogels, and phytosome technologies for improving the bioavailability, stability, and precision in delivering antidiabetic agents. Key areas ...read more

Guest Editor(s):Dr. null Badruddeen